HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transient macular edema after intracameral injection of a moderately elevated dose of cefuroxime during phacoemulsification surgery.

AbstractIMPORTANCE:
Intracameral injection of cefuroxime sodium (1 mg/0.1 mL) has been reported to reduce the risk of endophthalmitis following cataract surgery. In the United States it must be compounded, which is subject to dilution error. We describe a series of 13 eyes that received intracameral injection of cefuroxime sodium, 9 mg/0.1 mL, intraoperatively.
OBSERVATIONS:
On postoperative day 1, 6 of 13 eyes (46%; 95% CI, 19%-75%) had visual acuity of 20/70 or worse and macular edema. Spectral-domain optical coherence tomography of 2 eyes revealed central subfield thicknesses of 909 and 873 µm. On postoperative day 4, the mean (SD) central subfield thickness was 309 (78) µm in the 6 eyes with diagnosed macular edema, 279 (23) µm in the fellow eyes, and 271 (38) µm in the 7 exposed eyes without macular edema. The mean (SD) time to resolution of macular edema was 5.2 (1.3) days; the final central subfield thickness ranged from 193 to 293 µm. All eyes, except 2 with preexisting ocular comorbidity, had a best-corrected final visual acuity at 1 month of 20/30 or better. Significant corneal edema was not observed.
CONCLUSIONS AND RELEVANCE:
Intracameral injection of cefuroxime sodium at a dose of 9 mg/0.1 mL was associated with transient macular edema and diminished visual acuity in 6 of 13 exposed eyes (46%), resolving largely within 1 week.
AuthorsDavid C Wong, Michael D Waxman, Lisa J Herrinton, Neal H Shorstein
JournalJAMA ophthalmology (JAMA Ophthalmol) Vol. 133 Issue 10 Pg. 1194-7 (Oct 2015) ISSN: 2168-6173 [Electronic] United States
PMID26226062 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Cefuroxime
Topics
  • Anterior Chamber (drug effects)
  • Anti-Bacterial Agents (administration & dosage, adverse effects)
  • Cefuroxime (administration & dosage, adverse effects)
  • Drug Compounding (adverse effects)
  • Follow-Up Studies
  • Humans
  • Injections, Intraocular
  • Lens Implantation, Intraocular
  • Macular Edema (chemically induced, diagnosis)
  • Phacoemulsification
  • Tomography, Optical Coherence
  • Visual Acuity (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: